" class="no-js "lang="en-US"> Jim Lang Archives - Medtech Alert
Friday, March 31, 2023

Breaking News

Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS) ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment NADclinic Group, BioStarks and Do Not Age Announce Exclusive Partnership to Revolutionise Personalised Longevity PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa

Sort by:

Date

Top Post

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business | MTA

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business

NEC Corporation and NOI announced that NOI will be realigned as a subsidiary of NEC […]

Read more

News

 EVERSANA Unveils Global Price and Market Access Solution NAVLIN by EVERSANA | Pharmtech Focus

EVERSANA Unveils Global Price and Market Access Solution NAVLIN by EVERSANA

EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today […]

Industry News

 EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access

EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access, Channel and Patient Services

EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced […]

News

 EVERSANA ™ Expands Medical Information and Integrated Compliance Services Across Europe | Pharmtech Focus

EVERSANA ™ Expands Medical Information and Integrated Compliance Services Across Europe

EVERSANA ™, the pioneer of next generation commercial services to the global life sciences industry, today […]

Cardiovascular

 GENinCode Announces Major US Commercialisation Partnership with EVERSANA | Pharmtech Focus

GENinCode Announces Major US Commercialisation Partnership with EVERSANA

GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis

    Clinical Trials

     Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business

    Drug Development

     Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions

    Appointments

     Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board

    Appointments

     Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

    Diseases

     Read more